Doug Werner Email

Senior Scientist Synthetic Medicinal Chemistry . Vibliome Therapeutics

Current Roles

Employees:
13
Revenue:
$1.3M
About
Vibliome Therapeutics, LLC, has developed a novel systematic approach that enables the design of small molecule kinase inhibitors with unique selectivity profiles and extraordinary selectivity. There are over 500 kinases in the human genome which control nearly all cellular functions by transferring a polar phosphate group from ATP to regulatory serine, threonine, or tyrosine residues on proteins. Our mission to develop new therapeutic options for patients is backed by Deerfield Management in New York, a private equity firm committed to improving healthcare through investment, information and philanthropy. Consistent with our pioneering spirit, Vibliome’s research operations are located in Bozeman, Montana, on the edge of Yellowstone National Park and in the midst of world class skiing, fly fishing, unsurpassed access to nature and Montana’s largest research university. We are always looking for creative professionals with broad experience in drug discovery and development to join our team as we continue to grow.
Vibliome Therapeutics Address
533 East Mendenhall St
Bozeman, MT
Vibliome Therapeutics Email

Past Companies

Vibliome Therapeutics, LLCSenior Scientist Synthetic Medicinal Chemistry
BlinkBio IncSenior Scientist and Manager of External Chemistry
Coferon Inc.Research Scientist

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.